These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9285926)

  • 1. Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat.
    Czapla MA; Champion HC; Kadowitz PJ
    Peptides; 1997; 18(6):793-5. PubMed ID: 9285926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat.
    Champion HC; Kadowitz PJ
    Life Sci; 1997; 60(16):PL 241-5. PubMed ID: 9096263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the rat.
    Champion HC; Kadowitz PJ
    Life Sci; 1997; 61(26):PL 403-8. PubMed ID: 9416781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat.
    Champion HC; Bivalacqua TJ; Friedman DE; Zadina JE; Kastin AJ; Kadowitz PJ
    Peptides; 1998; 19(9):1595-602. PubMed ID: 9864068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat.
    Champion HC; Czapla MA; Kadowitz PJ
    Peptides; 1997; 18(5):729-32. PubMed ID: 9213368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat.
    Czapla MA; Champion HC; Kadowitz PJ
    Peptides; 1997; 18(8):1197-200. PubMed ID: 9396061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator responses to the endomorphin peptides, but not nociceptin/OFQ, are mediated by nitric oxide release.
    Champion HC; Bivalacqua TJ; Zadina JE; Kastin AJ; Kadowitz PJ
    Ann N Y Acad Sci; 1999; 897():165-72. PubMed ID: 10676445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tyr1]-nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the rat.
    Champion HC; Kadowitz PJ
    Biochem Biophys Res Commun; 1997 May; 234(2):309-12. PubMed ID: 9177265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitric oxide in mediating vasodilator responses to opioid peptides in the rat.
    Champion HC; Bivalacqua TJ; Zadina JE; Kastin AJ; Hyman AL; Kadowitz PJ
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):229-32. PubMed ID: 11906489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat.
    Champion HC; Pierce RL; Kadowitz PJ
    Regul Pept; 1998 Nov; 78(1-3):69-74. PubMed ID: 9879748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin, a novel endogenous ligand for the ORL1 receptor, has potent erectile activity in the cat.
    Champion HC; Wang R; Hellstrom WJ; Kadowitz PJ
    Am J Physiol; 1997 Jul; 273(1 Pt 1):E214-9. PubMed ID: 9252499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat.
    Feng CJ; Kang B; Kaye AD; Kadowitz PJ; Nossaman BD
    Life Sci; 1994; 55(22):PL433-8. PubMed ID: 7968246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin Has Vasodilator Activity in the Pulmonary Vascular Bed of the Rat.
    Nossaman BD; Champion HC; Kaye AD; Anwar M; Feng CJ; Kadowitz PJ
    J Cardiovasc Pharmacol Ther; 1998 Jul; 3(3):253-258. PubMed ID: 10684506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat.
    Champion HC; Zadina JE; Kastin AJ; Kadowitz PJ
    Life Sci; 1997; 61(26):PL 409-15. PubMed ID: 9416782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid secretion stimulated by centrally injected nociceptin in urethane-anesthetized rats.
    Ishihara S; Minowa S; Tsuchiya S; Horie S; Watanabe K; Murayama T
    Eur J Pharmacol; 2002 Apr; 441(1-2):105-14. PubMed ID: 12007927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tone-dependent vasodilator responses to proadrenomedullin NH2-terminal 20 peptide in the hindquarters vascular bed of the rat.
    Champion HC; Czapla MA; Friedman DE; Lambert DG; Murphy WA; Coy DH; Kadowitz PJ
    Peptides; 1997; 18(4):513-9. PubMed ID: 9210169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin.
    Ahmadi S; Liebel JT; Zeilhofer HU
    Eur J Pharmacol; 2001 Jan; 412(1):39-44. PubMed ID: 11166734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
    Hawkinson JE; Acosta-Burruel M; Espitia SA
    Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril on responses to bradykinin in the hindquarters vascular bed of the rat.
    Nossaman BD; Kaye AD; Kang B; Feng CJ; Kadowitz PJ
    Peptides; 1997; 18(4):491-4. PubMed ID: 9210166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hyperphagic effect of nociceptin/orphanin FQ in rats.
    Polidori C; de Caro G; Massi M
    Peptides; 2000 Jul; 21(7):1051-62. PubMed ID: 10998540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.